Quintiles Transitional Holdings Inc. (Q) Upgraded to “Buy” by Zacks Investment Research
Quintiles Transitional Holdings Inc. (NYSE:Q) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday. The firm presently has a $89.00 price target on the stock. Zacks Investment Research’s price target suggests a potential upside of 11.51% from the stock’s previous close.
According to Zacks, “Quintiles Transnational Holdings Inc. provides professional services, information and partnering solutions to the pharmaceutical services, biotechnology and healthcare industries. The Company has two segments: Product Development and Integrated Healthcare Services. It offers project management, clinical monitoring services, strategic planning and design services, consulting services contract sales, market entry/market exit, integrated channel management, patient engagement, market access and commercialization consulting, brand and scientific communication, and medical education services; outcome/observational services. The Company operates in Americas, Europe and Africa, and the Asia-Pacific. Quintiles Transnational Holdings Inc. is based in Durham, North Carolina. “
Q has been the subject of several other reports. Goldman Sachs Group Inc. upgraded Quintiles Transitional Holdings from a “not rated” rating to a “buy” rating and set a $94.00 target price for the company in a research note on Wednesday, October 5th. Pacific Crest upped their target price on Quintiles Transitional Holdings from $75.00 to $82.00 and gave the stock an “overweight” rating in a research note on Thursday, July 28th. Argus restated a “buy” rating and set a $85.00 target price (up from $75.00) on shares of Quintiles Transitional Holdings in a research note on Thursday, August 18th. Avondale Partners upgraded Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $62.00 to $87.00 in a research note on Monday, July 11th. Finally, Deutsche Bank AG upped their target price on Quintiles Transitional Holdings from $71.00 to $81.00 and gave the stock a “buy” rating in a research note on Thursday, July 28th. Six analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $81.85.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/11/quintiles-transitional-holdings-inc-q-upgraded-to-buy-by-zacks-investment-research.html
Quintiles Transitional Holdings (NYSE:Q) opened at 79.81 on Tuesday. The company has a market capitalization of $9.46 billion, a price-to-earnings ratio of 24.00 and a beta of 0.58. Quintiles Transitional Holdings has a 52-week low of $55.01 and a 52-week high of $81.45. The stock has a 50 day moving average price of $78.00 and a 200 day moving average price of $71.53.
Quintiles Transitional Holdings (NYSE:Q) last released its earnings results on Wednesday, July 27th. The company reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.03. Quintiles Transitional Holdings had a negative return on equity of 189.34% and a net margin of 6.83%. The firm earned $1.17 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same period in the prior year, the company earned $0.78 earnings per share. The company’s quarterly revenue was up 8.6% on a year-over-year basis. Analysts anticipate that Quintiles Transitional Holdings will post $3.82 EPS for the current fiscal year.
A number of hedge funds have recently modified their holdings of Q. Harris Associates L P acquired a new stake in shares of Quintiles Transitional Holdings during the second quarter worth $216,159,000. Brahman Capital Corp. acquired a new stake in shares of Quintiles Transitional Holdings during the second quarter worth $208,797,000. Janus Capital Management LLC increased its stake in shares of Quintiles Transitional Holdings by 435.8% in the second quarter. Janus Capital Management LLC now owns 3,324,138 shares of the company’s stock worth $217,132,000 after buying an additional 2,703,702 shares during the last quarter. CNH Partners LLC acquired a new stake in shares of Quintiles Transitional Holdings during the second quarter worth $56,435,000. Finally, Palestra Capital Management LLC acquired a new stake in shares of Quintiles Transitional Holdings during the second quarter worth $54,216,000. Hedge funds and other institutional investors own 92.78% of the company’s stock.
About Quintiles Transitional Holdings
Quintiles Transnational Holdings Inc is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. The Company’s segments include Product Development and Integrated Healthcare Services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.